| Literature DB >> 30546046 |
Naadir Ganief1, Jessica Sjouerman1, Claudia Albeldas1, Kehilwe C Nakedi1, Clemens Hermann1, Bridget Calder1, Jonathan M Blackburn2,3, Nelson C Soares4.
Abstract
Mycobacterium manages to evade the host cell immune system, partially owing to its ability to survive redox stress after macrophage engulfment. Exposure to redox stress has been linked to later replication, persistence, and latent infection. In this work, mass spectrometry was used to elucidate the cell-wide changes that occur in response to sublethal doses of hydrogen peroxide and nitric oxide over time, with Mycobacterium smegmatis being used as a model organism. A total of 3135 proteins were confidently assigned, of which 1713, 1674, and 1713 were identified under NO, H2O2, and control conditions, respectively. Both treatment conditions resulted in changes of protein expression from the DosR regulon as well as those related to lipid metabolism. Complementary to the changes in the proteome, sublethal exposure to NO and H2O2 improved the survival of the bacteria after macrophage infection. Our data indicate that pre-exposure to sublethal doses of these redox stressors causes an alteration in the expression of proteins related to lipid metabolism, suggesting a link between altered lipid metabolism and enhanced survival in macrophages.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30546046 PMCID: PMC6292918 DOI: 10.1038/s41426-018-0210-2
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Fig. 1Growth curves for Mycobacterium smegmatis cultures treated with various H2O2 concentrations at mid-log phase.
a The growth of M. smegmatis cultures as measured by absorbance at 600 nm when treated with increasing concentration of H2O2. Concentrations of 0–200 mM are represented. After treatment with 10 mM H2O2 cultures showed a slight growth defect, however growth recovered. Cultures treated with 50 mM and 100 mM H2O2 showed a larger growth defect when compared with cultures treated with 10 mM H2O2, and recovered growth much later. Cultures treated with 200 mM H2O2, showed an irreparable growth defect, suggesting in these conditions 200 mM H2O2 is lethal. b Arrows indicate the time points selected for further analysis at when treated with 10 mM H2O2
Fig. 2All replicates of all time points consisting of nine samples were used to generate a single plot for each treatment condition.
Stars, circles, and squares represent samples from T1, T2, and T3, respectively. T1 and T2 are less distinct from each other in both treatment conditions (a—DETA-NO and b—hydrogen peroxide), and in the untreated condition there is little notable clustering of the first two time points (c—untreated). The treatment conditions samples from T3 are more distinct from the other time points. Untreated samples at T3 are notably less distinct from samples from T1 and T2. In the treated conditions, as the time of exposure increases, the proteomic signature becomes more distinct
The median fold changes for all comparisons as well as the standard deviation of the fold change
| Time point comparison | Median fold change | Fold change standard deviation | Fold change cutoff(−) median − SD | Fold change cutoff( + ) median + SD |
|---|---|---|---|---|
| Untreated | ||||
| 1 vs 2 | 0.005 | 0.154 | −0.148 | 0.159 |
| 2 vs 3 | 0.008 | 0.297 | −0.290 | 0.305 |
| DETA-NO | ||||
| 1 vs 2 | 0.003 | 0.167 | −0.164 | 0.171 |
| 2 vs 3 | 0.009 | 0.283 | −0.273 | 0.292 |
| Hydrogen peroxide | ||||
| 1 vs 2 | −0.011 | 0.213 | −0.224 | 0.202 |
| 2 vs 3 | 0.015 | 0.227 | −0.212 | 0.243 |
The standard deviation was used to perform a fold change cutoff around the median fold change. Such that any fold change less than the fold change cutoff(−) was accepted as well as any fold change greater than the fold change cutoff( + ).
Fig. 3Proteins from each treatment condition that were found to have a differential abundance, as well as the overlap of these proteins between all conditions
a 30, 48, and 29 proteins from DETA-NO, hydrogen peroxide, and untreated, respectively, were assessed for the overlap in protein identity. Of these, 22, 40, and 23 proteins were found to be unique to DETA-NO, H2O2, and untreated conditions, respectively. b 177, 117, and 130 proteins belonging to the DETA-NO, H2O2, and untreated conditions were assessed for overlap. It was found that 81, 35, and 61 proteins were unique to DETA-NO, H2O2, and untreated conditions, respectively
Fig. 4Clusters of associated proteins found to have significant differences in abundances as a result of DETA-NO pre-exposure (as determined by String-db)
Clusters were determined by the EAGLE algorithm using ClusterVis via Cytoscape. The shape of the nodes denotes if a protein is a known drug target or virulence factor. Octagons represent known virulence factors, arrowheads represent known drug targets, and ellipses represent proteins that are not known to be either. The color of the nodes denotes the protein expression relative to the previous time point on a gradient of dark blue to deep red, with dark blue indicating the relatively lowest expression and deep red indicating the relatively highest expression. The color of the ring surrounding the nodes denotes when the protein showed differential expression, with black rings indicating that in both comparisons (T1 and T3) the protein showed altered expression, the yellow rings indicate altered expression in only the first comparison (T1), and the gray rings indicate altered expression in only the second comparison (T3). a shows proteins associated with carbohydrate metabolism involving pathways such as glycolysis/gluconeogenesis and the citrate cycle. b shows ribosomal proteins and some proteins associated with gene expression, most of which are downregulated. c shows the DosR regulon proteins
Summary of a subset of differentially abundant proteins due to DETA-NO treatment, from all time points
| Process | Uniprot accession | Gene name | Protein name | EC number | Fold change |
|---|---|---|---|---|---|
| Glycolysis/ gluconeogenesis | A0QU86 | MSMEG_2116 | PTS system, glucose-specific IIBC component (EC 2.7.1.-) (EC 2.7.1.69) | 2.7.1.-; 2.7.1.69 | 0.22 |
| Glycolysis/ gluconeogenesis | A0QU87 | MSMEG_2117 | Beta-glucoside-specific EII permease (PTS system sugar phosphotransferase component IIA) (EC 2.7.1.69) | 2.7.1.69 | 0.22 |
| Glycolysis/ gluconeogenesis | A0R170 | orB | Alpha oxoglutarate ferredoxin oxidoreductase, beta subunit | N/A | 0.27 |
| Glycolysis/ gluconeogenesis | A0R171 | MSMEG_4646 | Pyruvate flavodoxin/ferredoxin oxidoreductase-like protein (EC 1.2.7.3) (pyruvate synthase) | 1.2.7.3 | 0.31 |
| Glycolysis/ gluconeogenesis | A0QUA6 | pgm | Phosphoglucomutase PgmA (phosphoglucomutase, alpha- | 5.4.2.2 | 0.29 |
| Glycolysis/ gluconeogenesis | A0QVJ6 | MSMEG_2597 | Aldehyde dehydrogenase (EC 1.2.1.3) (aldehyde dehydrogenase AldC) (EC 1.2.1.-) | 1.2.1.3; 1.2.1.- | 0.37 |
| Glycolysis/ gluconeogenesis | A0QSN7 | MSMEG_1543 | Eptc-inducible aldehyde dehydrogenase (EC 1.2.1.3) | 1.2.1.3 | −0.36 |
| Glycolysis/ gluconeogenesis | A0QNQ5 | adhE1 | Oxidoreductase, zinc-binding dehydrogenase family protein (zinc-type alcohol dehydrogenase (E subunit) AdhE) (EC 1.1.1.1) | 1.1.1.1 | 0.30 |
| Glycolysis/ gluconeogenesis | A0R2Z4 | MSMEG_5287 | Alcohol dehydrogenase (EC 1.1.1.1) (dehydrogenase) | 1.1.1.1 | 0.35 |
| Lipid metabolism | A0R0B4 | kasA | 3-oxoacyl-(Acyl-carrier-protein) synthase 1 KasA (3-oxoacyl-[acyl-carrier-protein] synthase 1) (EC 2.3.1.41) | 2.3.1.41 | 0.37 |
| Lipid metabolism | A0R0B5 | kasB | 3-oxoacyl-(Acyl-carrier-protein) synthase 1 KasA (3-oxoacyl-[acyl-carrier-protein] synthase 2) (EC 2.3.1.41) | 2.3.1.41 | 0.28 |
| Lipid metabolism | A0R0B2 | fabD | Malonyl CoA-acyl-carrier protein transacylase (MCT) (EC 2.3.1.39) | 2.3.1.39 | 0.57 |
| Lipid metabolism | A0QVD5 | MSMEG_2536 | 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100) (short-chain dehydrogenase/reductase SDR) | 1.1.1.100 | −0.28 |
| Lipid metabolism | A0R4B3 | des | Acyl-acyl-carrier protein desaturase DesA1 (EC 1.14.19.2) (Fatty-acid desaturase) | 1.14.19.2 | 0.68 |
| Lipid metabolism | A0R726 | glpK | Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (glycerokinase) (GK) | 2.7.1.30 | 0.35 |
| Lipid metabolism | A0R2V0 | MSMEG_5242 | Diacylglycerol | 2.3.1.20 | 1.41 |
| Lipid metabolism | A0QY95 | MSMEG_3580 | Antigen 85-C (EC 2.3.1.-) | 2.3.1.- | 0.48 |
| Lipid metabolism | A0QVJ6 | MSMEG_2597 | Aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase AldC) (EC 1.2.1.-) | 1.2.1.3; 1.2.1.- | 0.37 |
| Lipid metabolism | A0QWI7 | fadD9 | Fatty-acid-CoA ligase FadD9 (EC 6.2.1.3) (NAD dependent epimerase/dehydratase family protein) | 6.2.1.3 | −0.49 |
| Response regulators | A0R4B7 | phoU | Phosphate-specific transport system accessory protein PhoU | N/A | −0.22 |
| Response regulators | A0QVF2 | MSMEG_2553 | Transcriptional regulator, TetR family protein | N/A | 0.25 |
| Response regulators | Q9F868 | regX3 | Sensory transduction protein regX3 | N/A | 0.46 |
| Response regulators | A0QTK2 | mtrA | DNA-binding response regulator MtrA | N/A | 0.34 |
| Response regulators | A0R2V2 | devR | LuxR family two-component response regulator (two-component transcriptional regulatory protein devr) | N/A | 0.79 |
| DosR regulon | A0QXB5 | MSMEG_3240 | DNA-binding response regulator, LuxR family protein | N/A | 0.49 |
| DosR regulon | A0R3C6 | MSMEG_5424 | Transcriptional regulator, TetR family protein | N/A | 0.31 |
| DosR regulon | A0R478 | MSMEG_5733 | Putative universal stress protein UspA (universal stress protein family protein) | N/A | 0.58 |
| DosR regulon | A0QZ91 | MSMEG_3940 | Universal stress protein family protein (UspA) | N/A | 0.72 |
| DosR regulon | A0QZ93 | MSMEG_3942 | Uncharacterized protein | N/A | 0.86 |
| DosR regulon | A0QZ96 | MSMEG_3945 | Universal stress protein family protein | N/A | 0.61 |
| DosR regulon | A0QZA2 | MSMEG_3952 | Uncharacterized protein | N/A | 0.87 |
| DosR regulon | A0QZA1 | MSMEG_3950 | Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950) | N/A | 0.90 |
| DosR regulon | A0R2V1 | MSMEG_5243 | Helix-turn-helix motif (pyridoxamine 5’-phosphate oxidase-related, FMN-binding protein) | N/A | 0.45 |
| DosR regulon | A0R2V3 | MSMEG_5245 | Universal stress protein family protein (UspA) | N/A | 0.72 |
| DosR regulon | A0R2V4 | MSMEG_5246 | Uncharacterized protein | N/A | 0.71 |
| DosR regulon | A0QZ83 | hspX | 14 kDa antigen (Heat shock protein hspX) | N/A | 1.05 |
| DNA repair | A0R3S7 | ku | Non-homologous end joining protein Ku | N/A | 0.28 |
| DNA repair | A0QW21 | MSMEG_2778 | Putative ribonuclease D (EC 3.1.-.-) (Ribonuclease D) | 3.1.-.- | 0.63 |
| DNA repair | A0R267 | MSMEG_5004 | DNA repair exonuclease (DNA repair exonuclease SbcD) | N/A | 0.43 |
| Protein expression | A0QWR4 | efp | Elongation factor P (EF-P) | N/A | −0.32 |
| Protein expression | A0QTQ8 | MSMEG_1930 | DEAD/DEAH box helicase | N/A | −0.38 |
| Protein expression | A0R218 | rho | Transcription termination factor Rho (EC 3.6.4.-) (ATP-dependent helicase Rho) | 3.6.4.- | −0.25 |
| Protein expression | A0R152 | rne | Ribonuclease E (RNase E) (EC 3.1.26.12) | 3.1.26.12 | −0.46 |
| Protein expression | Q59560 | recA | Protein RecA (recombinase A) | N/A | −0.33 |
| Protein expression | A0R7F4 | MSMEG_6892 | Replicative DNA helicase (EC 3.6.4.12) | 3.6.4.12 | −0.58 |
| Protein expression | A0QS66 | rpoC | DNA-directed RNA polymerase subunit beta’ (RNAP subunit beta’) (EC 2.7.7.6) (RNA polymerase subunit beta’) (transcriptase subunit beta’) | 2.7.7.6 | −0.39 |
| Protein expression | A0QSD1 | rplC | 50 S ribosomal protein L3 | N/A | −0.25 |
| Protein expression | A0QSG4 | rplF | 50 S ribosomal protein L6 | N/A | −0.25 |
| Protein expression | A0QS62 | rplJ | 50 S ribosomal protein L10 | N/A | −0.25 |
| Protein expression | A0QSG8 | rplO | 50 S ribosomal protein L15 | N/A | −0.26 |
| Protein expression | A0QSD6 | rplV | 50 S ribosomal protein L22 | N/A | −0.25 |
| Protein expression | A0QSD3 | rplW | 50 S ribosomal protein L23 | N/A | −0.18 |
| Protein expression | A0QV03 | rpmB | 50 S ribosomal protein L28 | N/A | −0.31 |
| Protein expression | A0QSL7 | rpsD | 30 S ribosomal protein S4 | N/A | −0.25 |
| Protein expression | A0QSG6 | rpsE | 30 S ribosomal protein S5 | N/A | −0.27 |
| Protein expression | A0QSD0 | rpsJ | 30 S ribosomal protein S10 | N/A | −0.30 |
The process the protein is involved in as well as aliases is shown. The EC number, also displayed on the KEGG pathway diagrams, is shown along with the fold change of each protein
Summary of a subset of differentially abundant proteins due to Hydrogen Peroxide treatment, from all time points
| Process | Uniprot accession | Gene name | Protein name | EC number | Fold change |
|---|---|---|---|---|---|
| Glycolysis/ gluconeogenesis | A0QSN7 | MSMEG_1543 | Eptc-inducible aldehyde dehydrogenase (EC 1.2.1.3) | 1.2.1.3 | −0.38 |
| Glycolysis/ gluconeogenesis | A0R171 | MSMEG_4646 | Pyruvate flavodoxin/ferredoxin oxidoreductase-like protein (EC 1.2.7.3) (pyruvate synthase) | 1.2.7.3 | 0.28 |
| Glycolysis/ gluconeogenesis | A0R5S7 | MSMEG_6297 | Aldehyde | 1.2.-.- | −0.41 |
| Glycolysis/ gluconeogenesis | A0R170 | orB | Alpha oxoglutarate ferredoxin oxidoreductase, beta subunit | N/A | 0,49 |
| Lipid metabolism | A0R0B5 | kasB | 3-oxoacyl-(Acyl-carrier-protein) synthase 1 KasA (3-oxoacyl-[acyl-carrier-protein] synthase 2) (EC 2.3.1.41) | 2.3.1.41 | 0.33 |
| Lipid metabolism | A0R4B3 | des | Acyl-acyl-carrier protein desaturase DesA1 (EC 1.14.19.2) (fatty-acid desaturase) | 1.14.19.2 | 1.23 |
| Response regulators | A0QPV5 | MSMEG_0532 | Transcriptional regulator, TetR family protein | N/A | 0,27 |
| Response regulators | A0QSV1 | MSMEG_1611 | Putative transcriptional regulatory protein (transcriptional regulator, TetR family protein, putative) | N/A | 0.32 |
| Response regulators | A0R5L8 | MSMEG_6236 | Response regulator, two-component system (two-component system, regulatory protein) | N/A | −0.51 |
| Response regulators | A0R2V2 | devR | LuxR family two-component response regulator (two-component transcriptional regulatory protein devr) | N/A | 0.44 |
| Response regulators | A0QUZ0 | leuD | 3-isopropylmalate dehydratase small subunit (EC 4.2.1.33) (alpha-IPM isomerase) (IPMI) (Isopropylmalate isomerase) | 4.2.1.33 | −0.42 |
| Response regulators | A0R4N7 | mce4B | MCE family protein MCE4b (virulence factor Mce family protein) | N/A | −0.23 |
| Response regulators | A0QTK2 | mtrA | DNA-binding response regulator MtrA | N/A | 0.32 |
| Response regulators | Q9F868 | regX3 | Sensory transduction protein regX3 | N/A | 0.30 |
| DosR regulon | A0QZ91 | MSMEG_3940 | Universal stress protein family protein (UspA) | N/A | 0.51 |
| DosR regulon | A0QZ93 | MSMEG_3942 | Uncharacterized protein | N/A | 0.54 |
| DosR regulon | A0QZ96 | MSMEG_3945 | Universal stress protein family protein | N/A | 0.43 |
| DosR regulon | A0QZA1 | MSMEG_3950 | Universal stress protein MSMEG_3950/MSMEI_3859 (USP MSMEG_3950) | N/A | 0.61 |
| DosR regulon | A0QZA2 | MSMEG_3952 | Uncharacterized protein | N/A | 0.63 |
| DosR regulon | A0R2V1 | MSMEG_5243 | Helix-turn-helix motif (pyridoxamine 5’-phosphate oxidase-related, FMN-binding protein) | N/A | 0.38 |
| DosR regulon | A0R2V3 | MSMEG_5245 | Universal stress protein family protein (UspA) | N/A | 0.43 |
| DosR regulon | A0R2V4 | MSMEG_5246 | Uncharacterized protein | N/A | 0.46 |
| DosR regulon | A0R478 | MSMEG_5733 | Putative universal stress protein UspA (Universal stress protein family protein) | N/A | 0.37 |
| Redox homeostasis | A0R683 | gltD | Glutamate synthase, NADH/NADPH, small subunit (EC 1.4.1.-) (Glutamate synthase, small subunit) | 1.4.1.- | −0.24 |
| Redox homeostasis | A0QWZ9 | sufB | FeS assembly protein SufB | N/A | −0.62 |
| Redox homeostasis | A0QTL3 | MSMEG_1885 | 2Fe-2S iron-sulfur cluster binding domain protein (oxidoreductase FAD-binding domain protein) | N/A | 0.91 |
| Protein expression | A0QZ11 | rbpA | RNA polymerase-binding protein RbpA | N/A | −0.26 |
| Protein expression | A0QS66 | rpoC | DNA-directed RNA polymerase subunit beta’ (RNAP subunit beta’) (EC 2.7.7.6) (RNA polymerase subunit beta’) (transcriptase subunit beta’) | 2.7.7.6 | −0.23 |
| Protein expression | A0R218 | rho | Transcription termination factor Rho (EC 3.6.4.-) (ATP-dependent helicase Rho) | 3.6.4.- | −0.21 |
| Protein expression | A0QVB8 | rpsB | 30 S ribosomal protein S2 | N/A | −0.22 |
| Protein expression | A0QSD7 | rpsC | 30 S ribosomal protein S3 | N/A | −0.22 |
| Protein expression | A0QSP9 | rpsI | 30 S ribosomal protein S9 | N/A | −0.22 |
| Protein expression | A0QSD0 | rpsJ | 30 S ribosomal protein S10 | N/A | −0.21 |
| Protein expression | A0QSL5 | rpsM | 30 S ribosomal protein S13 | N/A | −0.25 |
| Protein expression | A0QS62 | rplJ | 50 S ribosomal protein L10 | N/A | −0.23 |
| Protein expression | A0QSP8 | rplM | 50 S ribosomal protein L13 | N/A | −0.23 |
| Protein expression | A0QSG8 | rplO | 50 S ribosomal protein L15 | N/A | −0.25 |
| Protein expression | A0QSG5 | rplR | 50 S ribosomal protein L18 | N/A | −0.28 |
| Protein expression | A0QSG0 | rplX | 50 S ribosomal protein L24 | N/A | −0.23 |
The processes the protein is involved in as well as aliases are shown. The EC number, also displayed on the KEGG pathway diagrams, is shown along with the fold change of each protein
Fig. 5Clusters of associated proteins found to have significant differences in abundances as a result of H2O2 pre-exposure (as determined by String-db).
Clusters were determined by the EAGLE algorithm using ClusterVis via Cytoscape. The shape of the node denotes if a protein is a known drug target or virulence factor. Octagons represent known virulence factors and arrowheads represent known drug targets, whereas ellipses represent proteins that are not known to be either. The color of the nodes denotes the protein expression relative to the previous time point on a gradient of dark blue to deep red, with dark blue indicating the relatively lowest expression and deep red indicating the relatively highest expression. The color of the ring surrounding the nodes denotes when the protein showed differential expression, with black rings indicating that in both comparisons (T1 and T3) the protein showed altered expression, the yellow rings indicate altered expression in only the first comparison (T1), and the gray rings indicate altered expression in only the second comparison (T3). a shows proteins associated with carbohydrate metabolism, involving pathways such as; glycolysis/gluconeogenesis and the citrate cycle. b shows ribosomal proteins and some proteins associated with gene expression, all of which are downregulated. c shows the DosR regulon related proteins, all of which are upregulated
Fig. 6a CFU’s of uptake experiments. For T1, no significant differences between treatment conditions were observed. For T2, uptake following DETA-NO exposure was significantly lower than the untreated condition. At T3, both DETA-NO and H2O2 pre-exposure resulted in statistically significant lower uptake than the untreated condition. b CFU’s of survival experiments. For T1, only H2O2 pre-exposure resulted in a statistically significant increase in survival, with a 2.94-fold increase. For T2, pre-exposure with both DETA-NO and H2O2 resulted in a significant increase in survival, a 2.34- and 2.04-fold increase in survival, respectively. At T3 both DETA-NO and H2O2 pre-exposure resulted in a significant increase in survival compared with the untreated condition, with fold increases of 9.66 and 2.83, respectively. In both panels * represent statistically significant comparisons; * represents a p value < 0.05, *** represents a p value < 0.001 and **** represents a p value < 0.0001